Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinhyung Heo

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cell & Bioscience|January 24, 2023
Predictive biomarkers for the responsiveness of recurrent glioblastomas to activated killer cell immunotherapySohyun Hwang, Jaejoon Lim, Haeyoun Kang, et al.
Cancers|February 15, 2022
NOX2-Induced High Glycolytic Activity Contributes to the Gain of COL5A1-Mediated Mesenchymal Phenotype in GBMYoungjoon Park, Minwoo Park, Junhyung Kim, et al.
Genes|April 30, 2021
miR-542-3p Contributes to the HK2-Mediated High Glycolytic Phenotype in Human Glioma CellsJunhyung Kim, Min Woo Park, Young Joon Park, et al.
JHEP Reports : Innovation in Hepatology|March 2, 2026
Plasma GPC3 reflects tumor GPC3 expression and predicts clinical outcomes in advanced HCC treated with atezolizumab + bevacizumabDong Jun Shin, Sohyun Hwang, Beodeul Kang, et al.
Medcomm|January 20, 2026
Inhibition of FOS-Like Antigen 1 Reduces Chemoresistance to Temozolomide Through Stemness Reprogramming via IL-6/STAT3<sup>Tyr705</sup> PathwayJeongMin Sim, JeongMan Park, JinHyung Heo, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 13, 2025
Pathologist-Artificial Intelligence Concordance in HER2 Interpretation for Advanced Biliary Tract Cancer: Intraobserver, Interobserver, and Human-Artificial Intelligence VariabilityHyunchul Kim, Jinhyung Heo, Soo Ick Cho, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cell & Bioscience|January 24, 2023
Predictive biomarkers for the responsiveness of recurrent glioblastomas to activated killer cell immunotherapySohyun Hwang, Jaejoon Lim, Haeyoun Kang, et al.
Cancers|February 15, 2022
NOX2-Induced High Glycolytic Activity Contributes to the Gain of COL5A1-Mediated Mesenchymal Phenotype in GBMYoungjoon Park, Minwoo Park, Junhyung Kim, et al.
Genes|April 30, 2021
miR-542-3p Contributes to the HK2-Mediated High Glycolytic Phenotype in Human Glioma CellsJunhyung Kim, Min Woo Park, Young Joon Park, et al.
JHEP Reports : Innovation in Hepatology|March 2, 2026
Plasma GPC3 reflects tumor GPC3 expression and predicts clinical outcomes in advanced HCC treated with atezolizumab + bevacizumabDong Jun Shin, Sohyun Hwang, Beodeul Kang, et al.
Medcomm|January 20, 2026
Inhibition of FOS-Like Antigen 1 Reduces Chemoresistance to Temozolomide Through Stemness Reprogramming via IL-6/STAT3<sup>Tyr705</sup> PathwayJeongMin Sim, JeongMan Park, JinHyung Heo, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 13, 2025
Pathologist-Artificial Intelligence Concordance in HER2 Interpretation for Advanced Biliary Tract Cancer: Intraobserver, Interobserver, and Human-Artificial Intelligence VariabilityHyunchul Kim, Jinhyung Heo, Soo Ick Cho, et al.
Pageof 1